< 1 min read
March 13, 2013
LiveStrong CEO Doug Ulman talks to Chronicle of Philanthropy about the organization's reorientation after Lance Armstrong's confession.
"The Livestrong Foundation works to help people with cancer survive the disease. And as Livestrong attempts to survive after the revelation that its founder, Lance Armstrong, had used performance-enhancing drugs to fuel his seven Tour de France titles, it has leaned heavily on its mission of helping people battle a deadly disease—making it a central piece of its communications strategy...." More here.